2015
DOI: 10.1016/j.ejphar.2015.01.024
|View full text |Cite
|
Sign up to set email alerts
|

Pannexin-1 channels do not regulate α1-adrenoceptor-mediated vasoconstriction in resistance arteries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 26 publications
0
9
0
Order By: Relevance
“…The present 1 study showed mefloquine to inhibit responses to both 5-HT and U46619 (a thromboxane mimetic), indicating that mefloquine is not a selective pannexin inhibitor at the concentrations used in this study. Such argument was supported by a recent study by Angus et al (2015), who recently showed mefloquine (10μM to 20 μM) to demonstrate a wide range of inhibitory actions (Angus et al, 2015). For example, mefloquine (3μM to 10μM) inhibited the contractions mediated by vasopressin, phenylephrine, endothelin-1, U46619, sympathetic nerve stimulation and K (40 mM) in rat + and mouse small mesenteric arteries.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…The present 1 study showed mefloquine to inhibit responses to both 5-HT and U46619 (a thromboxane mimetic), indicating that mefloquine is not a selective pannexin inhibitor at the concentrations used in this study. Such argument was supported by a recent study by Angus et al (2015), who recently showed mefloquine (10μM to 20 μM) to demonstrate a wide range of inhibitory actions (Angus et al, 2015). For example, mefloquine (3μM to 10μM) inhibited the contractions mediated by vasopressin, phenylephrine, endothelin-1, U46619, sympathetic nerve stimulation and K (40 mM) in rat + and mouse small mesenteric arteries.…”
Section: Discussionmentioning
confidence: 90%
“…For example, Sridharan et al (2010) showed carbenoxolone (100µM) to inhibit the hypnotically induced ATP release from human erythrocytes (Sridharan et al, 2010). Similarly, Angus et al (2015) showed that carbenoxolone had no effect on agonist or nerve-induced activation of alpha-adrenoceptors in rat small mesenteric resistance arteries (Angus et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…The present study showed mefloquine to inhibit responses to both 5-HT and U46619 (a thromboxane mimetic), indicating that mefloquine is not a selective pannexin inhibitor at the concentrations used in this study. Such argument was supported by a recent study by Angus et al (2015), who recently showed mefloquine (10 μM to 20 μM) to demonstrate a wide range of inhibitory actions [27]. For example, mefloquine (3 μM to 10 μM) inhibited the contractions mediated by vasopressin, phenylephrine, endothelin-1, U46619, sympathetic nerve stimulation and K + (40 mM) in rat and mouse small mesenteric arteries.…”
Section: Effect Of Pannexin Inhibition On Responses To Na and Efs In mentioning
confidence: 90%
“…For example, Sridharan et al (2010) showed carbenoxolone (100 μM) to inhibit the hypnotically induced ATP release from human erythrocytes [26]. Similarly, Angus et al (2015) showed that carbenoxolone had no effect on agonist or nerve-induced activation of alpha-adrenoceptors in rat small mesenteric resistance arteries [27].…”
Section: Effect Of Pannexin Inhibition On Responses To Na and Efs In mentioning
confidence: 99%
“…First, a study using another muscular resistance artery of Panx1-deficient mice reported enhanced rather than reduced phenylephrine-induced contractions [118]. Moreover, there is also no evidence that Panx1 channels releasing ATP have any role in the constrictor actions of alpha1-adrenoceptor activation of small resistance arteries [151]. Clearly, more studies are needed before a consensus will be reached regarding involvement of Panx1 in alpha1-adrenergic receptor-mediated effects.…”
Section: Pannexins In Resistance Arteries and Arteriolesmentioning
confidence: 99%